Abstract
BackgroundEstrogen receptor positive breast cancer is commonly treated with aromatase inhibitors (AI). A well-known adverse effect of this therapy is osteoporosis and related bone fractures. National guidelines have promoted the...
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have